1 | Agrippal S1 (Influenza vaccination) | - | - | - | - | 1件: 46 46 |
2 | Belimumab plus Early Vaccination | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 |
3 | Belimumab plus Late Vaccination | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 |
4 | COVID-19 vaccination | - | - | - | - | 1件: 13 13 |
5 | Human papillomavirus vaccination (Gardasil) | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
6 | Influenza vaccination | - | - | - | - | 1件: 299 299 |
7 | Measles, Mumps, Rubella vaccination | - | - | - | - | 1件: 107 107 |
8 | Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) | 1件: Myelin basic protein Myelin basic protein | - | - | - | 1件: 13 13 |
9 | Prevenar vaccination | - | - | - | - | 1件: 46 46 |
10 | T cell vaccination | - | - | - | - | 1件: 13 13 |
11 | T-Cell Vaccination | - | - | - | - | 1件: 13 13 |
12 | Vaccination | - | - | - | - | 1件: 49 49 |
13 | Vaccination against TBE | - | - | - | - | 1件: 46 46 |
14 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件: 299 299 |